Trials / Conditions / Metastatic Chondrosarcoma
Metastatic Chondrosarcoma
5 registered clinical trials studyying Metastatic Chondrosarcoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors NCT06176989 | National Cancer Institute (NCI) | Phase 2 |
| Withdrawn | Lattice Stereotactic Body Radiation Therapy (Lattice SBRT) for Localized Unresectable or Metastatic Convention NCT04098887 | Washington University School of Medicine | N/A |
| Terminated | Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas NCT03670069 | Fred Hutchinson Cancer Center | Phase 1 |
| Completed | Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma NCT01330966 | Emerald Clinical Inc. | Phase 2 |
| Active Not Recruiting | Vismodegib in Treating Patients With Advanced Chondrosarcomas NCT01267955 | National Cancer Institute (NCI) | Phase 2 |